Modulation of Mucosal and Systemic Immunity by Hormonal Contraceptives

Stopped early

Conditions studied: Initiation of Oral Contraception (OC), Initiation of Depo-Provera (DMPA), Initiation of Mirena (LNG-IUD)

In brief

The investigators are conducting a research study to understand how cells responsible for fighting infection (immune cells) are affected by hormonal contraceptive use. The investigators hypothesize that progestin-containing hormonal contraceptives (i.e., Depo-Provera) inhibit host response to infection. To test this hypothesis, the investigators will collect blood and genital tract samples from women before and after their initiation of a hormonal contraceptive (either birth control pills, Depo-Provera, or Mirena).

Key facts

Study ID
NCT01750476
Run by
Thomas Cherpes, DVM, MD
People needed
7
Starts
2012-12-01
Expected to finish
2013-06-01
Last updated by the study team
2014-01-07

Who can join

Age: 15 and older, up to 25. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.